D. E. Shaw & Co., Inc. Recursion Pharmaceuticals, Inc. Transaction History

D. E. Shaw & Co., Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $428,233 - $727,950	46,904 Added 311.47%	61,963 $617,000
Q4 2023 Feb 14, 2024	SELL	$5.09 - $10.79 $44,018 - $93,311	-8,648 Reduced 36.48%	15,059 $148,000
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $78,170 - $188,131	11,862 Added 100.14%	23,707 $181,000
Q2 2023 Aug 14, 2023	SELL	$4.56 - $9.94 $871,201 - $1.9 Million	-191,053 Reduced 94.16%	11,845 $88,000
Q1 2023 May 15, 2023	BUY	$6.42 - $9.64 $1.3 Million - $1.96 Million	202,898 New	202,898 $1.35 Million

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.